Status:
COMPLETED
Utilization of Aspirin for Prevention of Pre-Eclampsia in Nigeria: A Explanatory Sequential Mixed Methods Study
Lead Sponsor:
Washington University School of Medicine
Collaborating Sponsors:
University of Abuja Teaching Hospital
Aminu Kano Teaching Hospital
Conditions:
Hypertensive Disorders of Pregnancy
Eligibility:
FEMALE
18-40 years
Brief Summary
The goal of this study is to evaluate the use of aspirin for the prevention of preeclampsia among moderate -to- high-risk pregnant women in tertiary care hospitals in Nigeria followed by a qualitative...
Detailed Description
Nigeria has the highest burden of maternal mortality worldwide accounting for over 1 in 4 of global maternal deaths. In a 2022 nationwide analysis of maternal outcomes in 76,563 deliveries across refe...
Eligibility Criteria
Inclusion
- Adult pregnant woman \> 18 years old / emancipated pregnant minors (\<18years), according to the stipulations of the Nigerian National Health Research Ethics Committee (NRHEC)
- \>12 weeks' gestation attending antenatal care clinics on 2nd or subsequent visit
- Those presenting to the labor and delivery room.
Exclusion
- Unable to provide consent
Key Trial Info
Start Date :
October 31 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 30 2024
Estimated Enrollment :
1200 Patients enrolled
Trial Details
Trial ID
NCT06053203
Start Date
October 31 2023
End Date
November 30 2024
Last Update
July 2 2025
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
National Hospital, Abuja
Abuja, Nigeria
2
University of Abuja Teaching Hospital
Gwagwalada, Nigeria
3
Aminu Kano Teaching Hospital
Kano, Nigeria
4
Murtala Muhammad Specialist Hospital
Kano, Nigeria